Overview
Deepak Chander is a Hematologist Oncology specialist and a Hematologist in Washington, Washington, D.c.. Dr. Chander is rated as an Experienced provider by MediFind in the treatment of Ampullary Cancer. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Small Cell Lung Cancer (SCLC), and ALK-Positive Non-Small Cell Lung Cancer.
His clinical research consists of co-authoring 2 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
110 Irving St Nw, Washington, DC 20010
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Inova Health Care Services
Timothy Cannon is an Oncologist and a Hematologist in Fairfax, Virginia. Dr. Cannon is rated as a Distinguished provider by MediFind in the treatment of Ampullary Cancer. His top areas of expertise are Colorectal Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, and Cholangiocarcinoma (Bile Duct Cancer). Dr. Cannon is currently accepting new patients.
Johns Hopkins University
Daniel Laheru is an Oncologist in Baltimore, Maryland. Dr. Laheru is rated as an Elite provider by MediFind in the treatment of Ampullary Cancer. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Laheru is currently accepting new patients.
Maryland Oncology Hematology PA
Jun Sun is a Hematologist Oncology specialist and a Hematologist in Brandywine, Maryland. Dr. Sun is rated as a Distinguished provider by MediFind in the treatment of Ampullary Cancer. His top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Anemia, and Pulmonary Embolism. Dr. Sun is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- Colorectal CancerDr. Chander isAdvanced. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Chander isAdvanced. Learn about Familial Colorectal Cancer.
- Lung AdenocarcinomaDr. Chander isAdvanced. Learn about Lung Adenocarcinoma.
- Lynch SyndromeDr. Chander isAdvanced. Learn about Lynch Syndrome.
- Neuroendocrine TumorDr. Chander isAdvanced. Learn about Neuroendocrine Tumor.
- Experienced
- Acute Mountain SicknessDr. Chander isExperienced. Learn about Acute Mountain Sickness.
- Adult Immune ThrombocytopeniaDr. Chander isExperienced. Learn about Adult Immune Thrombocytopenia.
- Ampullary CancerDr. Chander isExperienced. Learn about Ampullary Cancer.
- Anal CancerDr. Chander isExperienced. Learn about Anal Cancer.
- AnemiaDr. Chander isExperienced. Learn about Anemia.
- AngiosarcomaDr. Chander isExperienced. Learn about Angiosarcoma.